Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases

Background As advances in neonatal and pediatric care for patients affected by inherited metabolic diseases (IMD) improve their outcome and allow for better survival rates, there is a growing interest in the quality of life (QoL) of patients reaching adulthood. In order to address this subject we de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cazzorla, Chiara (VerfasserIn) , Burgard, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: May 2012
In: Molecular genetics and metabolism
Year: 2012, Jahrgang: 106, Heft: 1, Pages: 25-30
ISSN:1096-7206
DOI:10.1016/j.ymgme.2012.02.008
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.ymgme.2012.02.008
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1096719212000339
Volltext
Verfasserangaben:Chiara Cazzorla, Monica Del Rizzo, Peter Burgard, Chiara Zanco, Andrea Bordugo, Alberto B. Burlina, Alessandro P. Burlina

MARC

LEADER 00000caa a2200000 c 4500
001 1574000160
003 DE-627
005 20230427042850.0
007 cr uuu---uuuuu
008 180507s2012 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ymgme.2012.02.008  |2 doi 
035 |a (DE-627)1574000160 
035 |a (DE-576)504000160 
035 |a (DE-599)BSZ504000160 
035 |a (OCoLC)1341008317 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Cazzorla, Chiara  |e VerfasserIn  |0 (DE-588)1158506759  |0 (DE-627)1020519908  |0 (DE-576)504001760  |4 aut 
245 1 0 |a Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases  |c Chiara Cazzorla, Monica Del Rizzo, Peter Burgard, Chiara Zanco, Andrea Bordugo, Alberto B. Burlina, Alessandro P. Burlina 
264 1 |c May 2012 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.05.2018 
520 |a Background As advances in neonatal and pediatric care for patients affected by inherited metabolic diseases (IMD) improve their outcome and allow for better survival rates, there is a growing interest in the quality of life (QoL) of patients reaching adulthood. In order to address this subject we designed a study to evaluate the QoL of a group of adult IMD patients who are receiving various treatments, in a comprehensive manner. Methods A mixed-method study was conducted to assess the QoL in adult IMD patients. The multidimensional World Health Organization Quality of Life questionnaire (WHOQOL-100) was applied for quantitative evaluations, and an additional semi-standardized interview, was conducted for qualitative measurement of patients' perceptions of the impact of illness on their daily life, and the perceived adherence to their treatment recommendations. A total of 82 patients affected by IMD were enrolled. The inherited metabolic disorders included principally amino acids disorders, urea cycle defects, organic acidurias, carbohydrates disorders, and lysosomal disorders. The WHOQOL-100 and the semi-standardized interview were administered in a clinical setting to adult patients with IMD.Results The mean for the whole group indicates that adult patients with IMD can have a normal value of General QoL. Despite this value, the results of each domain show lower scores in the domains of perception of independence and quality of social relationships. We made a further analysis to compare the patients with dietary treatment with the patients with pharmacological treatment, and we observed a statistically significant difference in General QoL, in the Physical, Independence, Spiritual domains and in the facet of Medication. These results suggest that Global QoL measures might not be sufficient to assess the QoL for adult patients with IMD. Furthermore, the implementation of a qualitative semi-standardized interview, especially suitable for adult patients, added important features on illness perception and on perceived adherence to the treatment by adult IMD patients.Conclusion In this study we underlined the importance of applying multidimensional instruments, like WHOQOL-100, to evaluate the quality of life of adult patients with IMD. The WHOQOL-100 has been demonstrated to be a valid instrument to measure the QoL of IMD patients. Moreover, the administration of a tailored psychometric instrument in combination with a qualitative interview may help us to better characterize special issues related to IMD. Indeed, other factors beyond the physical manifestations of the disease, such as psychological wellbeing, social behavior, illness perception and adherence to the treatment, strongly influence QoL and may serve as valid targets for intervention to improve patients' care. We believe this kind of approach is especially useful for adult patients with inherited metabolic diseases. 
650 4 |a Adult patients 
650 4 |a Dietary treatment 
650 4 |a Fabry disease 
650 4 |a Inherited metabolic diseases (IMD) 
650 4 |a Phenylketonuria 
650 4 |a Quality of life 
700 1 |a Burgard, Peter  |e VerfasserIn  |0 (DE-588)1050864808  |0 (DE-627)785218416  |0 (DE-576)160485630  |4 aut 
773 0 8 |i Enthalten in  |t Molecular genetics and metabolism  |d Orlando, Fla. : Academic Press, 1998  |g 106(2012), 1, Seite 25-30  |h Online-Ressource  |w (DE-627)268125260  |w (DE-600)1471393-7  |w (DE-576)106869493  |x 1096-7206  |7 nnas  |a Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases 
773 1 8 |g volume:106  |g year:2012  |g number:1  |g pages:25-30  |g extent:6  |a Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases 
856 4 0 |u http://dx.doi.org/10.1016/j.ymgme.2012.02.008  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1096719212000339  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180507 
993 |a Article 
994 |a 2012 
998 |g 1050864808  |a Burgard, Peter  |m 1050864808:Burgard, Peter  |d 910000  |d 910500  |e 910000PB1050864808  |e 910500PB1050864808  |k 0/910000/  |k 1/910000/910500/  |p 3 
999 |a KXP-PPN1574000160  |e 3008062547 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 07.05.2018"],"recId":"1574000160","language":["eng"],"person":[{"roleDisplay":"VerfasserIn","display":"Cazzorla, Chiara","role":"aut","family":"Cazzorla","given":"Chiara"},{"display":"Burgard, Peter","roleDisplay":"VerfasserIn","role":"aut","family":"Burgard","given":"Peter"}],"title":[{"title_sort":"Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases","title":"Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases"}],"physDesc":[{"extent":"6 S."}],"relHost":[{"id":{"issn":["1096-7206"],"eki":["268125260"],"zdb":["1471393-7"]},"origin":[{"publisherPlace":"Orlando, Fla.","publisher":"Academic Press","dateIssuedKey":"1998","dateIssuedDisp":"1998-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Molecular genetics and metabolism","title_sort":"Molecular genetics and metabolism"}],"part":{"issue":"1","pages":"25-30","year":"2012","extent":"6","text":"106(2012), 1, Seite 25-30","volume":"106"},"pubHistory":["63.1998 -"],"recId":"268125260","language":["eng"],"note":["Gesehen am 14.02.20"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseasesMolecular genetics and metabolism"}],"name":{"displayForm":["Chiara Cazzorla, Monica Del Rizzo, Peter Burgard, Chiara Zanco, Andrea Bordugo, Alberto B. Burlina, Alessandro P. Burlina"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"May 2012"}],"id":{"doi":["10.1016/j.ymgme.2012.02.008"],"eki":["1574000160"]}} 
SRT |a CAZZORLACHAPPLICATIO2012